These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 29081214)
1. Potentiation of Th1-Type Immune Responses to Ko A; Wui SR; Ryu JI; Lee YJ; Hien DTT; Rhee I; Shin SJ; Park SA; Kim KS; Cho YJ; Lee NG J Microbiol Biotechnol; 2018 Jan; 28(1):136-144. PubMed ID: 29081214 [TBL] [Abstract][Full Text] [Related]
2. A novel liposome adjuvant DPC mediates Mycobacterium tuberculosis subunit vaccine well to induce cell-mediated immunity and high protective efficacy in mice. Liu X; Da Z; Wang Y; Niu H; Li R; Yu H; He S; Guo M; Wang Y; Luo Y; Ma X; Zhu B Vaccine; 2016 Mar; 34(11):1370-8. PubMed ID: 26845736 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and protective efficacy of DMT liposome-adjuvanted tuberculosis subunit CTT3H vaccine. Teng X; Tian M; Li J; Tan S; Yuan X; Yu Q; Jing Y; Zhang Z; Yue T; Zhou L; Fan X Hum Vaccin Immunother; 2015; 11(6):1456-64. PubMed ID: 25905680 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and protective efficacy of novel Mycobacterium tuberculosis antigens. Derrick SC; Yabe IM; Yang A; Kolibab K; Hollingsworth B; Kurtz SL; Morris S Vaccine; 2013 Sep; 31(41):4641-6. PubMed ID: 23906890 [TBL] [Abstract][Full Text] [Related]
5. Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine. Mosavat A; Soleimanpour S; Farsiani H; Sadeghian H; Ghazvini K; Sankian M; Jamehdar SA; Rezaee SA Infect Genet Evol; 2016 Apr; 39():163-172. PubMed ID: 26835592 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant Potential of Poly-α-l-Glutamine from the Cell Wall of Mycobacterium tuberculosis. Mani R; Gupta M; Malik A; Tandon R; Prasad R; Bhatnagar R; Banerjee N Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30104212 [TBL] [Abstract][Full Text] [Related]
7. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells. Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536 [TBL] [Abstract][Full Text] [Related]
8. Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4-HspX. Niu H; Hu L; Li Q; Da Z; Wang B; Tang K; Xin Q; Yu H; Zhang Y; Wang Y; Ma X; Zhu B Vaccine; 2011 Nov; 29(51):9451-8. PubMed ID: 22024175 [TBL] [Abstract][Full Text] [Related]
9. Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine. Gupta N; Garg S; Vedi S; Kunimoto DY; Kumar R; Agrawal B Front Immunol; 2018; 9():2371. PubMed ID: 30386336 [TBL] [Abstract][Full Text] [Related]
10. Differential Immunogenicity and Protective Efficacy Elicited by MTO- and DMT-Adjuvanted CMFO Subunit Vaccines against Ullah N; Hao L; Wu Y; Zhang Y; Lei Q; Banga Ndzouboukou JL; Lin X; Fan X J Immunol Res; 2020; 2020():2083793. PubMed ID: 32953889 [TBL] [Abstract][Full Text] [Related]
11. Cationic pH-sensitive liposome-based subunit tuberculosis vaccine induces protection in mice challenged with Mycobacterium tuberculosis. Szachniewicz MM; van den Eeden SJF; van Meijgaarden KE; Franken KLMC; van Veen S; Geluk A; Bouwstra JA; Ottenhoff THM Eur J Pharm Biopharm; 2024 Oct; 203():114437. PubMed ID: 39122053 [TBL] [Abstract][Full Text] [Related]
12. Combinational PRR Agonists in Liposomal Adjuvant Enhances Immunogenicity and Protective Efficacy in a Tuberculosis Subunit Vaccine. Hao L; Wu Y; Zhang Y; Zhou Z; Lei Q; Ullah N; Banga Ndzouboukou JL; Lin X; Fan X Front Immunol; 2020; 11():575504. PubMed ID: 33117374 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice. Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695 [TBL] [Abstract][Full Text] [Related]
14. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis. Chen YY; Lin CW; Huang WF; Chang JR; Su IJ; Hsu CH; Cheng HY; Hsu SC; Dou HY J Microbiol Immunol Infect; 2017 Feb; 50(1):90-96. PubMed ID: 25732698 [TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of bacillus calmette guerin and a tuberculosis subunit vaccine in cationic liposomes: increased immunogenicity and protection. Dietrich J; Billeskov R; Doherty TM; Andersen P J Immunol; 2007 Mar; 178(6):3721-30. PubMed ID: 17339470 [TBL] [Abstract][Full Text] [Related]
16. Microstructured liposome subunit vaccines reduce lung inflammation and bacterial load after Mycobacterium tuberculosis infection. Trentini MM; de Oliveira FM; Gaeti MP; Batista AC; Lima EM; Kipnis A; Junqueira-Kipnis AP Vaccine; 2014 Jul; 32(34):4324-32. PubMed ID: 24951861 [TBL] [Abstract][Full Text] [Related]